TipRanks
Go Ultimate55% OFF

Comparison Results

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
BIBProShares Ultra Nasdaq Biotechnology$120.53―0.95%103.75M
XLVHealth Care Select Sector SPDR Fund$184.87$196.25(6.16% Upside)0.08%48.89B
VHTVanguard Health Care ETF$342.33$381.34(11.39% Upside)0.09%20.70B
PBPHPortfolio Building Block World Pharma and Biotech Index ETF$31.35$32.90(4.96% Upside)0.13%1.17B
CANCTema Oncology ETF$42.29$60.99(44.23% Upside)0.75%216.18M
LFSCF/M Emerald Life Sciences Innovation ETF$43.60$66.87(53.39% Upside)0.54%125.43M
IBBQInvesco Nasdaq Biotechnology ETF$36.17$45.87(26.80% Upside)0.19%120.43M
HRTSTema Cardiovascular and Metabolic ETF$38.87$45.45(16.91% Upside)0.75%57.10M
OZEMRoundhill GLP-1 & Weight Loss ETF$30.70$48.04(56.51% Upside)0.59%55.57M

International Listings

OTC and non-US listings of funds similar to BIS.

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
IVBUFiShares NASDAQ US Biotechnology UCITS ETF$10.67$13.60(27.55% Upside)0.37%1.26B

Performance Comparison

0%20%40%60%80%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
BIBProShares Ultra Nasdaq Biotechnology120.5351.0573.47%
XLVHealth Care Select Sector SPDR Fund184.8742.8030.12%
VHTVanguard Health Care ETF342.3376.4828.77%
PBPHPortfolio Building Block World Pharma and Biotech Index ETF31.356.3025.14%
CANCTema Oncology ETF42.2911.6538.04%
LFSCF/M Emerald Life Sciences Innovation ETF43.6011.3135.02%
IBBQInvesco Nasdaq Biotechnology ETF36.1710.1138.81%
HRTSTema Cardiovascular and Metabolic ETF38.876.9621.81%
OZEMRoundhill GLP-1 & Weight Loss ETF30.702.027.03%

ETFs Similar to BIS FAQ

What is the cheapest alternative to BIS?
Among the ETFs similar to BIS, XLV (Health Care Select Sector SPDR Fund) has the lowest expense ratio, at 0.08% a year, compared with 0.95% for BIS.
BIS vs. BIB: what is the difference?
BIB (ProShares Ultra Nasdaq Biotechnology) is the first ETF in BIS's similar-ETF list. It has $103.75M in assets under management and a 0.95% expense ratio, against $1.73M and 0.95% for BIS. Compare their performance, price targets and Smart Scores in the table above.